Iktos

Description

Iktos develops an AI-driven platform for drug discovery. It supports molecule design, retrosynthesis, robotic synthesis, analysis, testing, and drug-candidate identification.

Related

• Relation TherapeuticsBuilds AI-driven drug discovery and development platforms to identify biology and advance molecules to clinical value inflection points for…
• Isomorphic LabsBuilds predictive and generative AI models for drug discovery, used to accelerate scientific discovery and design novel molecules for…
• WhiteLab GenomicsBuilds AI-driven platforms that predict optimal molecular constructs for genomic medicine; used by drug developers and research partners to…
• THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-enabled molecular modeling and drug discovery platforms for use by researchers and partners…
• Molecule.oneBuilds an AI-driven chemistry platform that integrates AI, lab automation, and data to enable near-autonomous research for drug discovery…
• NEXDOTDevelops UV-protective varnishes and electro‑optic components for preserving perfumes, cosmetics and supporting industrial customers in…
• HeartBeat.bioHeartBeat.bio develops Cardioid technology for human heart chamber models.
• RasynBuilds industrial compounds and formulations, defining material requirements, producing samples, testing specifications, and using models…
• Ever DyeDevelops a patented dye synthesis and attachment technology to lower carbon, energy use, and toxic chemicals in textile dyeing for fashion…
• EntalpicEntalpic develops AI tools for designing molecules and materials for industrial surface processes.
• Synthetic SciencesBuild foundation models for scientific research, providing machine-learning systems intended to support scientists’ research tasks,…